STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 69 filers reported holding STEMLINE THERAPEUTICS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $176,000 | -73.4% | 20,595 | -72.5% | 0.13% | -64.2% |
| Q3 2015 | $662,000 | -25.0% | 75,000 | 0.0% | 0.37% | -47.6% |
| Q2 2015 | $883,000 | -18.6% | 75,000 | 0.0% | 0.70% | -23.1% |
| Q1 2015 | $1,085,000 | -9.7% | 75,000 | +6.5% | 0.91% | -23.5% |
| Q4 2014 | $1,201,000 | – | 70,400 | – | 1.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 475,200 | $6,877,000 | 3.03% |
| Avoro Capital Advisors LLC | 475,000 | $6,873,000 | 2.64% |
| VHCP Management, LLC | 451,400 | $6,532,000 | 1.50% |
| Sio Capital Management, LLC | 140,000 | $2,026,000 | 1.15% |
| Opus Point Partners Management, LLC | 75,000 | $1,085,000 | 0.91% |
| Eventide Asset Management | 620,200 | $8,974,000 | 0.68% |
| Telemetry Investments, L.L.C. | 55,000 | $796,000 | 0.44% |
| Healthcare Value Capital, LLC | 25,000 | $362,000 | 0.40% |
| TFS CAPITAL LLC | 259,916 | $3,761,000 | 0.37% |
| FARALLON CAPITAL MANAGEMENT LLC | 672,562 | $9,732,000 | 0.14% |